During the past decade, Ogyi, Orszagos Gyogyszereszeti Intezet conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ogyi, Orszagos Gyogyszereszeti Intezet" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Ogyi, Orszagos Gyogyszereszeti Intezet" in a lesser frequency.

Most popular intervention types in "Ogyi, Orszagos Gyogyszereszeti Intezet" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "5-Fluorouracil (5-FU)" (1 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials) and "Leucovorin (LV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ogyi, Orszagos Gyogyszereszeti Intezet" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ogyi, Orszagos Gyogyszereszeti Intezet". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ogyi, Orszagos Gyogyszereszeti Intezet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ogyi, Orszagos Gyogyszereszeti Intezet, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".